Active Vitamin D (1,25 dihydroxyVitamin D) is associated with chronic pain in older australian men: The Concord Health and Ageing in Men Project

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 3, 2015, Pages 387-395

  Hirani, Vasant ^a,b,c   Blyth, Fiona M ^a   Naganathan, Vasi ^a   Cumming, Robert G ^a,b,c   Le Couteur, David G ^d   Handelsman, David J ^e   Waite, Louise M ^a   Seibel, Markus J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b School of Public Health   (United States)

^c Centre of Excellence in Population Ageing Research   (Australia)

^d University of Sydney   (Australia)

^e Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Calcitriol; Older men; Pain; Population study; Vitamin D

Indexed keywords

1,25-DIHYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; PARATHYROID HORMONE; VITAMIN D;

AGE; AGED; ANALOGS AND DERIVATIVES; AUSTRALIA; BLOOD; BODY MASS; CHRONIC PAIN; CROSS-SECTIONAL STUDY; GLOMERULUS FILTRATION RATE; HEALTH STATUS; HUMAN; MALE; PREVALENCE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AUSTRALIA; BODY MASS INDEX; CHRONIC PAIN; CROSS-SECTIONAL STUDIES; GLOMERULAR FILTRATION RATE; HEALTH STATUS; HUMANS; MALE; PARATHYROID HORMONE; PREVALENCE; VITAMIN D;

EID: 84927787398     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu126     Document Type: Article

References (46)

1. Hicks GE, Shardell M, Miller RR, et al. Associations between vitamin D status and pain in older adults: the Invecchiare in Chianti study. Am Geriatr Soc. 2008;56:785-791. doi:10.1111/j.1532-5415.2008.01644.x
2. Atherton K, Berry DJ, Parsons T, Macfarlane GJ, Power C, Hyppönen E. Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey. Ann Rheum Dis. 2009;68:817-822. doi:10.1136/ard.2008.090456
3. Hirani V. Vitamin D status and pain: analysis from the Health Survey for England among English adults aged 65 years and over. Br J Nutr. 2012;107:1080-1084. doi:10.1017/S0007114511003965
4. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003;78:1463-1470.
5. Knutsen KV, Brekke M, Gjelstad S, Lagerløv P. Vitamin D status in patients with musculoskeletal pain, fatigue and headache: a cross-sectional descriptive study in a multi-ethnic general practice in Norway. Scand J Prim Health Care. 2010;28:166-171. doi:10.3109/02813432. 2010.505407
6. Gloth FM III, Lindsay JM, Zelesnick LB, Greenough WB III. Can vitamin D deficiency produce an unusual pain syndrome? Arch Intern Med. 1991;151:1662-1664.
7. Lotfi A, Abdel-Nasser AM, Hamdy A, Omran AA, El-Rehany MA. Hypovitaminosis D in female patients with chronic low back pain. Clin Rheumatol. 2007;26:1895-1901.
8. Basaran S, Guzel R, Coskun-Benlidayi I, et al. Vitamin D status: effects on quality of life in osteoporosis among Turkish women. Qual Life Res. 2007;16:1491-1499.
9. Helliwell PS, Ibrahim GH, Karim Z, et al. Unexplained musculoskeletal pain in people of South Asian ethnic group referred to a rheumatology clinic-relationship to biochemical osteomalacia, persistence over time and response to treatment with calcium and vitamin D. Clin Exp Rheumatol. 2006;24:424-427.
10. Straube S, Derry S, Moore RA, McQuay HJ. Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst Rev. 2010;(1): CD007771. doi:10.1002/14651858. CD007771. pub2
11. Mithal A, Wahl DA, Bonjour JP, et al.; Committee IOF, IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20:1807-1820. doi:10.1007/s00198-009-0954-6
12. Hewison M, Burke F, Evans KN, et al. Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease. J Steroid Biochem Mol Biol. 2007;103:316-321.
13. Lips P. Relative value of 25 (OH) D and 1, 25 (OH) 2D measurements. J Bone Miner Res. 2007;22:1668-1671.
14. Holick MF. Vitamin D deficiency: what a pain it is. Mayo Clin Proc. 2003;78:1457-1459.
15. Cumming RG, Handelsman D, Seibel MJ, et al. Cohort profile: the Concord Health and Ageing in Men Project (CHAMP). Int J Epidemiol. 2008;38:374-378. doi:10.1093/ije/dyn071
16. Hirani V, Naganathan V, Cumming RG, et al. Associations between frailty and serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin d concentrations in older Australian men: the concord health and ageing in men project. J Gerontol A Biol Sci Med Sci. 2013;68:1112-1121. doi:10.1093/gerona/glt059
17. Ware J Jr, Kosinski M, Keller SD. A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
18. Blyth FM, March LM, Brnabic AJ, Jorm LR, Williamson M, Cousins MJ. Chronic pain in Australia: a prevalence study. Pain. 2001;89:127-134.
19. Thomas E, Mottram S, Peat G, Wilkie R, Croft P. The effect of age on the onset of pain interference in a general population of older adults: prospective findings from the North Staffordshire Osteoarthritis Project (NorStOP). Pain. 2007;129:21-27.
20. Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46:153-162.
21. Shiekh J, Yesavage J. Geriatric Depression Scale: recent findings and development of a short version. In: Brink T, ed. Clinical Gerontology: A Guide to Assessment and Intervention. New York, NY: Howarth Press; 1986;165-173.
22. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
23. Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol. Med. 1994;24, 145-153.
24. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156.
25. Levey AS, Coresh J, Greene T, et al. Expressing the MDRD equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J Am Soc Nephrol. 2005;16:69A.
26. Division of Drug Information Service, College of Pharmacy, University of Iowa. IDIS drug vocabulary and thesaurus description. http://itsnt14.its.uiowa.edu/. Accessed May 19, 2011.
27. Day RO, Graham GG. Non-steroidal anti-inflammatory drugs (NSAIDs). BMJ. 2013;346. doi:10.1136/bmj.f3195
28. Gröber U, Kisters K. Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinol. 2012;4:158-66. doi:10.4161/derm.20731
29. Agresti A. Categorical Data Analysis. Vol. 2. New York, NY: Wiley; 2002.
30. National Kidney Foundation. Kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.. http://www.kidney.org/professionals/KDOQI/guidelines.cfm. Accessed September 24, 2013.
31. Al Faraj S, Al Mutairi K. Vitamin D deficiency and chronic low back pain in Saudi Arabia. Spine. 2003;28:177-179.
32. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726-776. doi:10.1210/er.2008-0004
33. Bischoff HA, Borchers M, Gudat F, et al. In situ detection of 1, 25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J. 2001;33:19-24.
34. Simpson RU, Thomas GA, Arnold AJ. Identification of 1, 25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem. 1985;260:8882-8891.
35. Turner MK, Hooten WM, Schmidt JE, et al. Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain. Pain Med. 2008;9:979-984. doi:10.1111/j.1526-4637.2008.00415.x
36. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine. 2010;77:552-557. doi:10.1016/j.jbspin. 2010.09.018
37. Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med. 2011;11:325-335.
38. Pedersen LB, Nashold FE, Spach KM, Hayes CE. 1, 25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res. 2007;85:2480-2490.
39. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4-8.
40. Oelzner P, Müller A, Deschner F, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int. 1997;23:193-198.
41. Slovik DM, Adams JS, Neer RM, et al. Deficient production of 1, 25-dihydroxyvitamin D in elderly osteoporoticpatients. N Engl J Med. 1981;305:372-374.
42. Francis RM, Peacock M, Barkworth SA. Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing. 1984;13:1420.
43. Bischoff-Ferrari HA, Borchers M, Gidat F, et al. Vitamin D Receptor Expression in human muscle tissue decreases with age. J Bone Miner Res. 2004;19:265-269.
44. Erkal MZ, Wilde J, Bilgin Y, et al. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int. 2006;17:1133-1140.
45. Straube S, Andrew Moore R, Derry S, McQuay HJ. Vitamin D and chronic pain. Pain. 2009;141:10-13. doi:10.1016/j. pain. 2008.11.010
46. Holden CA, McLachlan RI, Pitts M, et al. Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet. 2005;366:218-224.